Related Articles
Family history in participants of breast cancer screening
Influence of a family history of breast and/or ovarian cancer on breast cancer outcomes
Different survival determinants of metastatic breast cancer patients treated with endocrine therapy or chemo-endocrine therapy.
Surgical margin and breast recurrence after breast-conserving therapy.
c-erbB-2 status is an independent predictor of survival after first recurrence.